"OMIII - Országos Mentális, Ideggyógyászati és Idegsebészeti Intézet - National Institute of Mental Health, Neurology and Neurosurgery"

During the past decade, Országos Klinikai Idegtudományi Intézet conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Országos Klinikai Idegtudományi Intézet" #1 sponsor was "Takeda" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Eisai Limited" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "GlaxoSmithKline" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Országos Klinikai Idegtudományi Intézet" #1 collaborator was "Medtronic Bakken Research Center" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator and "Bausch Health Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Országos Klinikai Idegtudományi Intézet" are "Epilepsy" (3 trials), "Migraine" (3 trials), "Dravet Syndrome (DS)" (2 trials), "Intracranial Aneurysm" (2 trials) and "Lennox Gastaut Syndrome (LGS)" (2 trials). Many other conditions were trialed in "Országos Klinikai Idegtudományi Intézet" in a lesser frequency.

Most popular intervention types in "Országos Klinikai Idegtudományi Intézet" are "Drug" (19 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Soticlestat" (3 trials), "YKP3089" (2 trials), "Zonisamide" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Országos Klinikai Idegtudományi Intézet" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Országos Klinikai Idegtudományi Intézet". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Országos Klinikai Idegtudományi Intézet, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Országos Klinikai Idegtudományi Intézet, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".